| Date Filed | Type | Description |
| 05/25/2023 |
4
| Decker Lisa Lynn (Chief Business Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 961 shares
@ $11.71, valued at
$11.3k
Sold 1,244 shares
@ $12.3005, valued at
$15.3k
Sold 15 shares
@ $13.005, valued at
$195.1 |
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2023 |
4
| Decker Lisa Lynn (Chief Business Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 1,061 shares
@ $18.732, valued at
$19.9k
|
|
| 12/20/2022 |
4
| Decker Lisa Lynn (Chief Business Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 1,598 shares
@ $18.7746, valued at
$30k
Sold 886 shares
@ $19.3595, valued at
$17.2k
|
|
| 11/28/2022 |
4
| Decker Lisa Lynn (Chief Business Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 861 shares
@ $21.3765, valued at
$18.4k
Sold 397 shares
@ $21.9914, valued at
$8.7k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| Decker Lisa Lynn (Chief Business Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 11/17/2021 |
4
| Decker Lisa Lynn (Chief Business Officer) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 367 shares
@ $50.99, valued at
$18.7k
|
|
| 04/26/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2019 |
3
| Decker Lisa Lynn (Chief Business Officer) has filed a Form 3 on Atreca, Inc. |